Accelerating Clinical Trials

AI

Using AI to forge the future of rare disease clinical trials

“The biggest shifts in rare disease clinical research are occurring in platform and basket trials, which from the perspective of…

Partner Content

Expert analysis: the latest in HIV research and clinical trials

Features

Revealed: drug development companies best positioned to weather future industry disruption

Filings

Future of Work: Cipla tops list of filing mentions

News

UK to study long Covid in £20m research drive

News

Clinical trials charter to bolster global health defences born at G7

Features

Small world: how decentralisation is improving paediatric clinical trials

Accelerating Clinical Trials

THREAD Q&A: bridging the gap between patients and trials with social media

Accelerating Clinical Trials

How a drug development plan can save your biotech money

Accelerating Clinical Trials

The benefit of running clinical trials in Asia-Pacific for biotech companies

Accelerating Clinical Trials

Is Australia the future for successful first-in-human clinical studies?

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close